Sign in
Not yet recruitingNo phase

ZeroOCD: Learn to Overcome Contamination OCD With Your Smartphone

Key facts

Who runs it
VU University of Amsterdam
Where
Belgium, Netherlands, Sweden, and Switzerland4 sites in 4 countriesChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
189 people, planned
Started
21 Sept 2025
Expected to end
May 2027
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • ZeroOCD
  • Videoconferencing CBT
Record updated
26 September 2025

Who can take part

Age
18 years to 64 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • • OCD symptoms, mean score > 7 on the Yale Brown Obsessive Compulsive Scale (Y-BOCS); Fear of contamination OCD symptoms, mean score > 6 on the Padua Inventory contamination fear subscale (PI); Having access to a compatible smartphone; Having an internet connection; Proficiency in one of the countries' languages (i.e., Dutch/ Flemish, German, or Swedish); Willing to participate in the research study and provide informed consent

Who cannot take part

  • • Having been diagnosed with bipolar or psychotic disorder (self-report); Severe depressive symptoms (Patient Health Questionnaire, PHQ-9, score > 20); Reporting suicidality (PHQ-9, item 9 > 2 points at screening); Fear of contamination due to disorder other than OCD (clinical judgment based on results from the Yale Brown Obsessive Compulsive Scale, Y-BOCS, Generalized Anxiety Disorder-7 items, GAD-7, Short Health Anxiety Inventory, SHAI); Parallel psychological treatment; Non-stable dosage of psychoactive medication during the last three months or planned changes during the study period

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

This trial has no sites in United States.

It has sites in 4 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is a three-arm randomized controlled trial designed to evaluate the efficacy of a smartphone-based augmented reality (AR) cognitive behavioral therapy (CBT) app, called ZeroOCD, for individuals with elevated contamination-related obsessive-compulsive disorder (OCD) symptoms. The AR-CBT app will be compared to both an active control condition (manualized CBT via videoconferencing) and a waitlist control group.

The 3 groups in the trial

  • ZeroOCD AR-CBT App + 3 therapist support sessionsTreatment being tested

    Participants will use the ZeroOCD smartphone application, which delivers 9 modules of augmented reality exposure therapy and cognitive behavioral therapy principles. This group will also receive 3 videoconferencing sessions with a therapist at the beginning, middle, and end of the 10-week treatment period.

    Treatment: ZeroOCD

  • Videoconferencing CBTExisting treatment, for comparison

    Participants will receive 9 weekly sessions of manualized Cognitive Behavioral Therapy with Exposure and Response Prevention (ERP) delivered via videoconferencing by trained therapists.

  • Waitlist control groupNo study treatment, for comparison

    Participants in this group will receive access to the ZeroOCD app with therapist support on request after a 10-week waiting period.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
ZeroOCD: Learn to Overcome Contamination OCD With Your Smartphone: An Augmented Reality Cognitive Behavioral Therapy App for Obsessive-Compulsive Disorder: Randomized Controlled Trial
Criteria questions
Built from NCT07194473, who can take part
Record updated
26 September 2025